InstalabSTD Panel
Should you take a STD Panel test?
This test is most useful if any of these apply to you.
9 biomarkers included
- Herpes (HSV) 1 IgGMeasures antibodies to herpes type 1, the usual cause of cold sores that can also cause genital herpes.A positive result shows past exposure to HSV-1, most often oral but sometimes genital.
- Herpes (HSV) 2 IgGMeasures antibodies to herpes type 2, the usual cause of genital herpes, indicating past exposure rather than a current outbreak.A low positive is frequently a false positive and should be confirmed before it is treated as established herpes.
- Chlamydia RNADetects the genetic material of chlamydia, the most commonly reported bacterial infection here, finding cases that cause no symptoms.A positive result means a current, curable chlamydia infection that can cause infertility if left untreated.
- Neisseria Gonorrhoeae RNADetects the genetic material of gonorrhea directly, far more sensitive than older culture testing for this often silent infection.A positive result means a current gonorrhea infection at the sampled site that should be treated promptly.
- RPR ScreenScreens for syphilis by detecting your body's reaction to the infection, sensitive to active disease and useful for tracking treatment response.A reactive result points to possible active syphilis and needs a syphilis-specific confirmatory test and titer.
- HIV Infection ScreenThe front-line HIV test, combining antibody and antigen detection to catch both established and recent infection in a single step.A reactive result flags possible HIV infection and moves straight to confirmatory testing before any diagnosis is made.
- HIV-1 AntibodyPart of the confirmatory HIV step, identifying antibodies specific to HIV-1 after a reactive initial screen.Confirms an immune response to HIV-1, the most common HIV type worldwide.
- HIV-1 AntigenMeasures the p24 viral protein that appears within days of infection, shortening the window before HIV can be detected.A positive p24 protein can catch recent HIV-1 infection before antibodies have formed.
- HIV-2 AntibodyDistinguishes HIV-2, a less common type that resists several standard HIV medications, so identifying it directly changes treatment.Identifying HIV-2 matters because some first-line HIV drugs do not work against it.
About STD Panel
Most sexually transmitted infections cause no symptoms, which is exactly how they spread. You can feel completely healthy and still carry chlamydia, gonorrhea, syphilis, or HIV (the virus that causes AIDS), and pass any of them to a partner without knowing.
This panel checks for several of these infections in a single visit, using blood and urine. It gives a fuller picture than any one test alone, because these infections tend to cluster in the same people and one positive result often signals raised odds of another.
What This Panel Reveals
The tests here answer four separate questions about your sexual health, bundled into one order. Together they map current bacterial infection, syphilis status, HIV status, and past exposure to herpes.
Two of the tests look for chlamydia and gonorrhea using nucleic acid amplification testing (a method that copies and detects a pathogen's genetic material). This approach finds far more infection than older culture methods. In a review of urine testing, one high-performing amplification method detected about 92.5% of chlamydia infections in women while staying correct in more than 97% of uninfected people; simpler urine methods can miss up to about 10% more infections than a vaginal swab.
The RPR screen (rapid plasma reagin, a test for your body's reaction to syphilis) is good at flagging active disease, but it is not specific to syphilis alone, so a reactive result is confirmed with a second, syphilis-specific test. Its sensitivity depends on the stage of infection, and in one small study measured against a syphilis-specific standard, the standard RPR card test caught about 86.4% of cases.
The HIV portion looks for both HIV antibodies and a viral protein called p24 that appears early, before antibodies form. Adding the p24 protein shortens the blind window right after infection. If the first screen is reactive, follow-up tests separate the HIV-1 antibody, HIV-1 antigen, and HIV-2 antibody signals to pin down what is actually present.
Two tests measure IgG antibodies (proteins your immune system makes after an infection) to herpes simplex virus types 1 and 2, which reflect past exposure rather than a current outbreak. The Centers for Disease Control and Prevention and the U.S. Preventive Services Task Force advise against routine herpes antibody screening in people without symptoms, because these tests produce false positives and a positive result rarely changes what you do. They carry the most weight when you have unexplained symptoms or a partner known to have genital herpes.
How to Read Your Results Together
No single line tells the whole story. The value of the panel is in the pattern across the results.
| Pattern | What It Suggests |
|---|---|
| Chlamydia or gonorrhea positive, everything else negative | A current, curable bacterial infection. Treat it, notify partners, and retest in about three months. |
| RPR reactive | Possible active syphilis. A syphilis-specific confirmatory test and titer separate active from past treated infection. |
| Any bacterial infection positive | Raised odds of a second infection. Among adults with early syphilis, 27% also had chlamydia or gonorrhea. |
| Herpes type 2 antibody positive, low value, no symptoms | Often a false positive. Confirm with a second test before treating it as established herpes. |
The HIV result deserves its own reading. The initial screen is built to be highly sensitive, so a reactive result is a starting point that always moves to confirmatory testing, not a diagnosis. A negative HIV screen soon after a risk event can also miss very recent infection, since even the early p24 protein takes days to appear.
What to Do with Your Results
A positive chlamydia, gonorrhea, or syphilis result is treatable, usually with antibiotics, and warrants prompt follow-up plus partner notification. A reactive HIV screen goes to confirmatory testing before any diagnosis is made, and modern treatment makes HIV a manageable condition when caught early.
Because one infection raises the odds of another, a single positive is a reason to complete the full panel rather than treat one bug in isolation. Consider adding tests for infections this panel does not cover, such as trichomonas, hepatitis B, and hepatitis C.
If you are sexually active with new or multiple partners, retest at least once a year, and every three to six months if your risk is higher. Always retest about three months after treatment to confirm the infection cleared, since serial testing is what catches reinfection before it spreads again.
When Results Can Be Misleading
A few things affect this whole panel at once. Every test has a window period, the gap after exposure before an infection becomes detectable, so testing too soon after a risk event can miss a real infection. The herpes antibodies alone can take up to 12 weeks to appear.
Sampling site matters for chlamydia and gonorrhea. A urine sample can miss throat and rectal infections, so if those sites were exposed, they need their own swabs to be checked. A clean urine result does not clear an untested site.
A negative panel is reassuring but not absolute, especially soon after exposure or when symptoms are present. If you have symptoms, let a clinician guide testing regardless of a clean result.